Sign In
Buy HUGE
$0.0899
+0 (+0%)
At Close: Nov 15, 2024
Vancouver, British Columbia--(Newsfile Corp. - June 23, 2020) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9), a specialty, biotech pharmaceutical R&D; company, focused on developing, over t
FSD Pharma Reports Favorable Topline Results from Phase 1 First-in-Human Safety and Tolerability Study of Ultramicronized PEA
06:30am, Monday, 22'nd Jun 2020
FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) ("FSD Pharma" or the "Company") today announced favorable topline results from its Phase 1 randomized, double-blind, placebo-controlled study
FSD Pharma Announces Closing of C$10.125 Million Private Placement to Institutional Investors
03:39pm, Tuesday, 09'th Jun 2020
TORONTO , June 9, 2020 /CNW/ - FSD Pharma Inc. (HUGE.CN) (HUGE.CN) (0K9A.F) (the "Company") announces the closing of a previously announced private placement of 1,500,000 of the Company's Class B
By Steven Ralston, CFA CSE:HUGE.CN | NASDAQ:HUGE READ THE FULL HUGE.CN RESEARCH REPORT FSD Pharma (CSE:HUGE.CN) (NASDAQ:HUGE) continues to evolve into a specialty, biotech pharmaceutical R&D; company
FSD Pharma Inc. Announces C$10.125 Million Private Placement
01:43pm, Thursday, 04'th Jun 2020
The Company has also agreed to issue common share purchase warrants to purchase 1,500,000 Shares of the Company. The Company has granted the investors an option to acquire up to an additional C$10.1
Covid Report: Small Biotech Doubles On Plans To Test A Coronavirus Drug
08:20pm, Wednesday, 03'rd Jun 2020
Shares of FSD Pharma doubled Wednesday after the small-cap biotech company announced plans to study a potential coronavirus treatment. The drug is called ultramicronized PEA.
FSD Pharma Receives U.S. FDA Approval to design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis
06:30am, Wednesday, 03'rd Jun 2020
Severe COVID-19 is characterized by an over-exuberant inflammatory response that may lead to a cytokine storm and ultimately death. FSD Pharma is focused on developing FSD-201 for its anti-inflammato
FSD Pharma Monetizes Non-Core Asset with Sale of Partial Equity Stake in Pharmadrug Inc.
12:30pm, Thursday, 21'st May 2020
FSD Pharma Monetizes Non-Core Asset with Sale of Partial Equity Stake in Pharmadrug Inc.
FSD Pharma Reports First Quarter 2020 Financial Results
09:12pm, Thursday, 14'th May 2020
FSD Pharma Reports First Quarter 2020 Financial Results
Nintendo Switch, PayPal Hack: 160,000 Users Fall Into Huge Breach of Players' Details
03:48pm, Wednesday, 29'th Apr 2020
Protect your Nintendo and PayPal accounts at all costs!
Trump Signs Huge New Economic Relief Spending Package
08:50pm, Friday, 24'th Apr 2020
Trump signs huge new economic relief spending package
ESPAOL • Empresas de Cannabis con Acciones el NYSE y NASDAQ: Una Lista Completa
05:47pm, Tuesday, 14'th Apr 2020
Articulo via El Planteo.Mientras la industria del cannabis sigue avanzando, mas y mas compañias se mueven para conseguir que sus acciones esten en las listas de las bolsas de valores estadounidenses
A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies
01:50pm, Thursday, 09'th Apr 2020
As the cannabis industry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ.Canadian medical marijuana producer Aphria Inc (NYSE: APH
FSD Pharma Takes Steps to Mitigate the Impact of COVID-19 on its Cannabis Production Facility in Cobourg, Ontario
01:17pm, Monday, 23'rd Mar 2020
The Company's actions are aligned with evolving guidance from provincial and local Canadian health officials. Effective immediately, FSD Pharma management has implemented a systematic and orderly sca
Vancouver, British Columbia--(Newsfile Corp. - March 10, 2020) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9), a specialty, biotech pharmaceutical R&D; company focused on developing, over tim
